Spexis announces the appointment of Gonçalo Bernardes, Ph.D., as acting Head of Chemical Biology

Spexis AG (SIX: SPEX), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced that the company has appointed Gonçalo Bernardes, PhD, as acting Head of …

Read Full Article